The effect of bowel resection on survival in advanced epithelial ovarian cancer

Gynecologic Oncology
W JaegerN Lang

Abstract

FIGO stage III ovarian cancer is further categorized according to the size of tumor, but not according to the organs affected. In this study we evaluated the outcome of patients with and without macroscopic bowel involvement in stage III ovarian cancer. This retrospective study analyzed the outcome of 194 ovarian cancer patients with FIGO III with and without bowel involvement who were operated on in our institution between 1985 and 1994. The study demonstrated that maximum tumor reduction without remaining macroscopic cancer offered the best overall survival times in FIGO III ovarian cancer patients. However, whenever the bowel was involved, even maximum bowel resections did not prolong survival compared to patients with remaining tumor after surgery. This retrospective study demonstrated that bowel involvement in ovarian cancer had a bad prognosis and that survival in these patients could not substantially be prolonged when the affected parts of bowel were resected. To further substantiate these findings, future studies on advanced ovarian cancer should differentiate between patients with and without bowel involvement.

References

Jan 1, 1991·Archives of Gynecology and Obstetrics·E PetruS Hilsenbeck
Sep 1, 1990·Geburtshilfe und Frauenheilkunde·E BurghardtH Stettner
May 1, 1990·The Australian & New Zealand Journal of Obstetrics & Gynaecology·R H Hammond, C R Houghton
Jul 1, 1984·Gynecologic Oncology·G DelgadoE S Petrilli
Jun 1, 1994·Gynecologic Oncology·F Guidozzi, J H Ball
May 1, 1993·Geburtshilfe und Frauenheilkunde·W KuhnJ R Siewert

❮ Previous
Next ❯

Citations

Dec 14, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·G E ChalkiadakisV Georgoulias
Jan 8, 2015·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Robert BachmannCornelia Bachmann
Jun 7, 2006·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·S AbdulM E L Paterson
Jan 5, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·F PlottiR Angioli
May 12, 2009·Gynecologic Oncology·Yong Jung SongSang-Yoon Park
Jun 7, 2007·Mayo Clinic Proceedings·Giovanni D AlettiLynn C Hartmann
Nov 26, 2008·Gynecologic Oncology·Giovanni D AlettiKirsten Hall Long
Oct 7, 2008·Gynecologic Oncology·Mitchel S Hoffman, Emmanuel Zervose
Dec 14, 2005·The Journal of Obstetrics and Gynaecology Research·Osamu TakahashiToshinobu Tanaka
Oct 22, 2008·The Journal of Obstetrics and Gynaecology Research·Ali AyhanKunter Yuce
Sep 27, 2006·Journal of the American College of Surgeons·Giovanni D AlettiWilliam A Cliby
Aug 1, 2006·Gynecologic Oncology·Scott M EisenkopWei-Chien Michael Lin
Oct 6, 2005·Gynecologic Oncology·Scott M EisenkopWei-Chien Michael Lin
Sep 13, 2005·Gynecologic Oncology·Giovanni D AlettiWilliam A Cliby
Aug 11, 2007·American Journal of Obstetrics and Gynecology·Mitchel S HoffmanJorge Lockhart
May 30, 2006·American Journal of Obstetrics and Gynecology·Stephen J TebesMitchel S Hoffman
Aug 16, 2005·American Journal of Obstetrics and Gynecology·Mitchel S HoffmanEdward C Grendys
Sep 29, 2011·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·V GallottaA Fagotti
Nov 23, 2011·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·S GouyP Morice
Apr 15, 2011·The Cochrane Database of Systematic Reviews·Christine AngHeather O Dickinson
Jan 6, 2006·Obstetrics and Gynecology·Giovanni D AlettiWilliam A Cliby
Apr 22, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Anton OseledchykMignon-Denise Keyver-Paik
Oct 30, 2018·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Selçuk ErkilinçMuzaffer Sanci
Jan 16, 2007·Current Opinion in Obstetrics & Gynecology·Osamu Takahashi, Toshinobu Tanaka

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.